Imtiaz Ahmed Khan

This inventor holds 10 USPTO granted patents and 11 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignees: Ge Healthcare Limited, King's College London. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Imtiaz Ahmed Khan. Retrieved from https://idiyas.com/inventor/imtiaz-ahmed-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 11)

% Patents Active = 90.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Amersham, GB (2015 - 2022)
Buckinghamshire, GB (2020 - 2023)

Company Filing History:

10 out of 191

Ge Healthcare Limited

patents

1 out of 196

King's College London

patents

where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527884 - Use of cyclodextrins as a radiostabilizer (2026-01-20),

2. 12162009 - Solid phase purification (2024-12-10),

3. 11565257 - Stabilized radiolabelling reaction (2023-01-31),

4. 11311636 - Radiotracer compositions and methods (2022-04-26),

5. 10759747 - Alkylation method (2020-09-01),

6. 10300156 - Radiotracer compositions and methods (2019-05-28),

7. 10220105 - Radiolabelling method (2019-03-05),

8. 9125954 - [object Object] (2015-09-08),

9. 9085518 - Method for the synthesis of 18F-labelled molecules (2015-07-21),

10. 9061996 - Solid phase extraction method (2015-06-23),

Title: Imtiaz Ahmed Khan: Innovator in Radiochemistry

Introduction

Imtiaz Ahmed Khan is a notable inventor based in Amersham, GB. He has made significant contributions to the field of radiochemistry, holding a total of nine patents. His work primarily focuses on the synthesis of injectable compositions that utilize [F]-labelled pyridaben derivatives.

Latest Patents

Among his latest patents, Khan has developed a method for solid phase purification. This invention provides a method for synthesizing an injectable composition that is amenable to automation. The purification process is carried out using solid phase extraction (SPE) alone. Another significant patent is the stabilized radiolabelling reaction, which offers a method for synthesizing an injectable composition that improves upon prior methods. This method also utilizes solid phase extraction (SPE) for a more efficient purification process.

Career Highlights

Throughout his career, Imtiaz Ahmed Khan has worked with prominent organizations such as GE Healthcare Limited and King's College London. His experience in these institutions has allowed him to advance his research and contribute to innovative solutions in the field of radiochemistry.

Collaborations

Khan has collaborated with notable colleagues, including Graeme McRobbie and Torgrim Engell. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Imtiaz Ahmed Khan is a distinguished inventor whose work in radiochemistry has led to significant advancements in the synthesis of injectable compositions. His contributions continue to influence the field and demonstrate the importance of innovation in healthcare.

Profile summary based on public USPTO records.